Evidence map›Paper›PMID 39905861›Full record

ArticleIET systems biology

StackAHTPs: An explainable antihypertensive peptides identifier based on heterogeneous features and stacked learning approach.

Ali Ghulam, Muhammad Arif, Ahsanullah Unar, Maha A Thafar, Somayah Albaradei, Apilak Worachartcheewan

Abstract read
In one paragraph

Article in IET systems biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ali GhulamInformation Technology Centre, Sindh Agriculture University, Tandojam, Sindh, Pakistan.ORCID 0000-0001-5166-2213
Muhammad ArifCollege of Science and Engineering, Hamad Bin Khalifa University, Doha, Qatar.ORCID 0000-0003-3950-6618
Ahsanullah UnarDepartment of Precision Medicine, University of Campania 'L. Vanvitelli', Naples, Italy.
Maha A ThafarDepartment of Computer Science, College of Computers and Information Technology, Taif University, Taif, Saudi Arabia.
Somayah AlbaradeiDepartment of Computer Science, Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah, Saudi Arabia.
Apilak WorachartcheewanDepartment of Community Medical Technology, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.

Funding

Mahidol University International CollegeTaif University, Saudi Arabia TU-DSPP-2025-57
6 · The paper itself

Abstract

Hypertension, often known as high blood pressure, is a major concern to millions of individuals globally. Recent studies have demonstrated the significant efficacy of naturally derived peptides in reducing blood pressure. Hypertension is one of the risks associated with cardiovascular disorders and other health problems. Naturally sourced bioactive peptides possessing antihypertensive properties provide considerable potential as viable substitutes for conventional pharmaceutical medications. Currently, thorough examination of antihypertensive peptide (AHTPs), by using traditional wet-lab methods is highly expensive and labours. Therefore, in-silico approaches especially machine-learning (ML) algorithms are favourable due to saving time and cost in the discovery of AHTPs. In this study, a novel ML-based predictor, called StackAHTP was developed for predicting accurate AHTPs from sequence only. The proposed method, utilise two types of feature descriptors Pseudo-Amino Acid Composition and Dipeptide Composition to encode the local and global hidden information from peptide sequences. Furthermore, the encoded features are serially merged and ranked through SHapley Additive explanations (SHAP) algorithm. Then, the top ranked are fed into three different ensemble classifiers (Bagging, Boosting, and Stacking) for enhancing the prediction performance of the model. The StackAHTPs method achieved superior performance compare to other ML classifiers (AdaBoost, XGBoost and Light Gradient Boosting (LightGBM), Bagging and Boosting) on 10-fold cross validation and independent test. The experimental outcomes demonstrate that our proposed method outperformed the existing methods and achieved an accuracy of 92.25% and F1-score of 89.67% on independent test for predicting AHTPs and non-AHTPs. The authors believe this research will remarkably contribute in predicting large-scale characterisation of AHTPs and accelerate the drug discovery process. At https://github.com/ali-ghulam/StackAHTPs you may find datasets features used.

Indexed as

Antihypertensive AgentsComputational BiologyMachine LearningPeptidesAlgorithmsHumansAntihypertensive AgentsPeptidesbioinformaticsbiology computingfeature extractionproteins

Identifiers

PMID39905861
PMCPMC11794993

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.